- Differential Effects of Two Widely Used Solvents, DMSO and Ethanol, on the Growth and Recovery of Trypanosoma cruzi Epimastigotes in Culture
-
Cevallos A, Herrera J, López-Villaseñor I, Hernández R
- KMID: 2374808
- Korean J Parasitol.
- 2017 Feb;55(1):81-84.
- doi: 10.3347/kjp.2017.55.1.81
Trypanosoma cruzi is the etiological agent of Chagas disease. Epimastigote forms of T. cruzi can be readily cultured in axenic conditions. Ethanol and dimethyl sulfoxide (DMSO) are commonly used solvents... -
- CITED
-
- Close
- SHARE
-
- Close
- Detection of Human Anti-Trypanosoma cruzi Antibody with Recombinant Fragmented Ribosomal P Protein
-
Kim YH, Yang Z, Lee J, Ahn HJ, Chong CK, Maricondi , Dias RF, Nam HW
- KMID: 2459483
- Korean J Parasitol.
- 2019 Aug;57(4):435-437.
- doi: 10.3347/kjp.2019.57.4.435
Chagas disease is caused by the protozoan parasite Trypanosoma cruzi, and is endemic in many Latin American countries. Diagnosis is based on serologic testing and the WHO recommends two or... -
- CITED
-
- Close
- SHARE
-
- Close
- Molecular Characterization of Trypanosoma cruzi Tc8.2 Gene Indicates Two Differential Locations for the Encoded Protein in Epimastigote and Trypomastigote Forms
-
Kian D, Lancheros , Damiani IA, Fernandes , Pinge-Filho P, dos Santos MRM, da Silveira JF, Nakamura C, da Silva J, Yamada-Ogatta SF, Yamauchi L
- KMID: 2381767
- Korean J Parasitol.
- 2015 Aug;53(4):483-488.
- doi: 10.3347/kjp.2015.53.4.483
This report describes the molecular characterization of the Tc8.2 gene of Trypanosoma cruzi. Both the Tc8.2 gene and its encoded protein were analyzed by bioinformatics, while Northern blot and RT-PCR... -
- CITED
-
- Close
- SHARE
-
- Close
- Assessing the Archaeoparasitological Potential of Quids As a Source Material for Immunodiagnostic Analyses
-
Morrow JJ, Reinhard K
- KMID: 2360524
- Korean J Parasitol.
- 2016 Oct;54(5):605-616.
- doi: 10.3347/kjp.2016.54.5.605
In the present study, quids from La Cueva de los Muertos Chiquitos (CMC) were subjected to ELISA tests for 2 protozoan parasites, Toxoplasma gondii (n=45) and Trypanosoma cruzi (n=43). The... -
- CITED
-
- Close
- SHARE
-
- Close
- Quantification of Immunoglobulin G against Trypanosoma cruzi in Individuals with Chronic Chagas Disease Treated with Nifurtimox and Evaluated in Prolonged Follow-Up
-
Muñoz G, Vergara C, MartÃnez , Apt W, Zulantay I
- KMID: 2441605
- Korean J Parasitol.
- 2019 Feb;57(1):39-41.
- doi: 10.3347/kjp.2019.57.1.39
In the indeterminate chronic period of Chagas disease (ChD) the treatment has not been conclusive, because the serological negativization requires many years. This study aims to evaluate the efficacy of... -
- CITED
-
- Close
- SHARE
-
- Close
- Evaluation of SD BIOLINE Chagas Ab Rapid Kit
-
Ji MJ, Noh JS, Cho BK, Cho YS, Kim SJ, Yoon BS
- KMID: 1781593
- Korean J Lab Med.
- 2009 Feb;29(1):48-52.
- doi: 10.3343/kjlm.2009.29.1.48
BACKGROUND: Chagas' disease is caused by Trypanosoma cruzi, a protozoan parasite, which is transmitted by blood-sucking bugs or through blood transfusion or organ transplantation. It is endemic in Central and... -
- CITED
-
- Close
- SHARE
-
- Close
- Inhibition of ER Stress by 2-Aminopurine Treatment Modulates Cardiomyopathy in a Murine Chronic Chagas Disease Model
-
Ayyappan J, lizardo K, Wang S, Yurkow E, Nagajyothi JF
- KMID: 2455094
- Biomol Ther.
- 2019 Jul;27(4):386-394.
- doi: 10.4062/biomolther.2018.193
Trypanosoma cruzi infection results in debilitating cardiomyopathy, which is a major cause of mortality and morbidity in the endemic regions of Chagas disease (CD). The pathogenesis of Chagasic cardiomyopathy (CCM)... -
- CITED
-
- Close
- SHARE
-
- Close
